The QualityStocks Daily Friday, April 12th, 2019

Today's Top 3 Investment Newsletters

QualityStocks (ZOOM) +100.00%

StockMarketWatch (TRNX) +47.46%

NetworkNewsWire (VPRB) +35.52%

The QualityStocks Daily Stock List

MJardin Group, Inc. (MJARF)

NetworkNewsWire, Business Wire, Insider Financial, Stockhouse, MarketWatch, Morningstar, Barchart, The Street, New Cannabis Ventures, CannabisMarketCap, Trading View, and Seeking Alpha reported previously on MJardin Group, Inc. (MJARF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

MJardin Group, Inc. is a worldwide cannabis management platform. The Company has wide-ranging experience in cultivation, processing, distribution and retail with over 30 cultivation facilities under operation. It continues to pursue strategic expansion and mergers and acquisitions (M&A) opportunities across worldwide legal cannabis markets. MJardin Group lists on the OTC Markets Group's OTCQX. The Company is based in Denver, Colorado and Toronto, Ontario.

MJardin, for greater than a decade, has refined cultivation methodologies, developed state-of-the-art facilities, and implemented vertical integration for and on behalf of license owners. The Company now has a multi-country 36 asset portfolio with industry leading yields.

MJardin owns or jointly owns assets across the complete cannabis supply chain in Canada and the United States for cultivation, processing, distribution and retail. It offers turnkey management services to develop, operate and staff cannabis cultivation and processing facilities across the United States and Canada. Moreover, it provides additional turnkey facility management and project funding in a product streaming model to partners.

This past January, 3 Sixty Risk Solutions Ltd. announced that the Company, which operates via its wholly-owned subsidiary, 3 Sixty Secure Corp., entered into a multi-year service agreement to provide guarding and secure transport services to an affiliate of MJardin Group. This agreement provides a complete set of security services to MJardin facilities in Canada. This includes security patrols and equipment monitoring, and also secure transport of cannabis products.

At the beginning of April, MJardin Group announced the completion of an Agreement, wherein the Nova Scotia Mi'kmaq First Nations (Mi'kmaq) will own a 51 percent stake in AtlantiCann Medical, Inc. (AMI). With this Agreement, MJardin Group and the Halef Group will own 39 percent and 10 percent of AMI, respectively. In connection with the partnership created under the Agreement, MJardin Group, the Mi'kmaq, and the Halef Group are considering expansion of their relationship, including retail.

AMI (Halifax, Nova Scotia) is a licensed joint venture (JV) cultivator. It has a 48,000 square foot facility with a production capacity of 6,000 kg annually (Phase 1), and an additional 20,000 square feet (Phase 2) expected by the end of this year that is anticipated to double AMI's production capacity.

MJardin Group, Inc. (MJARF), closed Friday's trading session at $1.85, even for the day, on 89,034 volume with 164 trades. The average volume for the last 3 months is 63,154 and the stock's 52-week low/high is $1.11/$6.684.

chart

Auto Trader Group plc (ATDRY)

Penny Stock Tweets, Stock Digest, Penny Stock Hub, Stock Scores, Wallmine, Marketbeat, Market Screener, Stockopedia, Zacks, Barchart, Street Insider, Wallet Investor, Dividend Investor, Investors Hangout, GuruFocus, Morningstar, YCharts, MarketWatch, and The Street reported earlier on Auto Trader Group plc (ATDRY), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Established in 1977, Auto Trader Group plc operates in the digital automotive marketplace in the United Kingdom (UK) and Ireland. The Company offers its products to retailers and home traders, and logistics firms. It also offers vehicle advertisement on its Websites for private sellers. In addition, it offers insurance and loan financing products to consumers and display advertising on its Websites for manufacturers and their advertising agencies.

Auto Trader Group lists on the OTC Markets. The Company has its corporate office in Manchester, UK. The Company was 32nd in the Sunday Times Best Companies to Work For 2018.

Auto Trader is a 100 percent digital business. In 2013, the Company successfully completed the transition from a print title and became a completely digital marketplace. Of note is that 94 advert views every second take place on its site.

Auto Trader Group is the UK's largest digital automotive marketplace. The Company has greater than 90 percent prompted brand awareness with consumers. Auto Trader Group attracts circa 55 million cross platform visits monthly. Moreover, 70 percent of these visits come through mobile devices. More than 80 percent of UK automotive retailers advertise on autotrader.co.uk.

Furthermore, 450k cars are listed on Auto Trader at any one time and the web portal is the 12th biggest website in the UK. Auto Trader has a 3x larger consumer audience versus its nearest competitor. It is the No.1 trusted automotive classified brand in the UK. In addition, 93 percent of UK consumers know who Auto Trader Group is. For car buyers, Auto Trader Group has added pricing indicators to signal the best priced vehicles. For retailers and manufacturers, the Company added a Premium level for retailers wanting to grow faster. Auto Trader Group's corporate mission is to lead the digital future of the UK automotive marketplace.

Auto Trader Group plc (ATDRY), closed Friday's trading session at $1.78, up 2.30%, on 325,058 volume with 81 trades. The average volume for the last 3 months is 224,343 and the stock's 52-week low/high is $1.169/$1.769.

chart

Flux Power Holdings, Inc. (FLUX)

StreetWise Reports, MarketWatch, Stockhouse, Business Wire, Seeking Alpha, GlobeNewswire, The Street, Barchart, InvestorsHub, Equity Clock, Wallet Investor, YCharts, Zacks, Market Screener, and Proactive Investors reported previously on Flux Power Holdings, Inc. (FLUX), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Flux Power Holdings, Inc. is a developer of advanced lithium batteries for industrial applications, including electric forklifts and airport ground support equipment. The Company's solutions use its proprietary battery management system and in-house engineering and product design. Flux Power sells mainly to lift equipment OEM's (Original Equipment Manufacturers), their dealers and battery distributors. Formed in 2009 and OTCQB-listed, Flux Power Holdings has its head office in Vista, California.

Flux Power initially concentrated on electric automobiles. It turned to industrial equipment in 2013. The Company develops advanced lithium-ion batteries for industrial uses, including its first-ever UL 2271 Listed lithium-ion "LiFT Pack" forklift batteries. Flux Power batteries deliver improved performance, extended cycle life, and lower total cost of ownership than legacy lead-acid solutions. The Company's current products include advanced battery packs for motive power in the lift equipment and airport ground support markets.

Flux Power's Class 3 Walkie LiFT Pack was introduced in 2014. It is the only pack tested and approved by major OEM's: Toyota, Raymond, and Crown Equipment. UL approval was attained in 2016: the only UL Listed pack in the forklift industry for multiple forklift brands. The Company has its Class 3 Walkie Pallet Jack; its Class 1 Counter Balance; and also its Class 3 End Rider, Class 2 Narrow Aisle, and Airport GSE equipment.

The Company also has its Flux Packs: Cells and Patented Electronics. This is a battery for Class 3 forklifts -- "walkie" pallet jacks. The Flux modular design is based on this "Walkie" pallet pack. Software and firmware are located in BCM (Battery Control Module) and BMSM (Battery Management System Modules).

Flux Lithium-Ion "LiFT Packs" run longer shifts and offer 30-50 percent electricity savings. They support multiple shifts (that is fewer batteries). Moreover, they have a 5 Year Warranty (walkies).

Recently, Flux Power Holdings announced that it was selected by a major international forklift manufacturer to supply lithium-ion batteries for the forklift manufacturer's walkie pallet jack forklift line, pursuant to a private label OEM relationship. Flux Power is providing a custom-designed lithium-ion energy storage solution for the forklift manufacturer's walkie pallet jack lift trucks.

Flux Power Holdings, Inc. (FLUX), closed Friday's trading session at $1.31, up 6.50%, on 5,186 volume with 2 trades. The average volume for the last 3 months is 3,543 and the stock's 52-week low/high is $0.4375/$3.349.

chart

Amplify Energy Corp. (AMPY)

Simply Wall St, Stockhouse, Whale Wisdom, Stock Invest, Zacks, Tech Stock Standard, Trading View, Dividend Investor, Market Screener, YCharts, Capital Cube, Wallmine, Wallet Investor, 4-Traders, and Marketbeat reported earlier on Amplify Energy Corp. (AMPY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Amplify Energy Corp. is an independent oil and natural gas company listed on the OTC Markets' OTCQX. The Company engages in the acquisition, development, exploration and production of oil and natural gas properties. Its operational focus is in the Rockies, offshore California, East Texas/North Louisiana and South Texas. Amplify Energy has its corporate headquarters in Houston, Texas.

An upstream company, Amplify Energy's properties comprise mature, legacy oil and natural gas fields. The Company's emphasis is on maintaining production across its high-quality asset base and executing on its strategic priorities.

Amplify Energy's properties mainly consist of operated working interests (WIs) in producing and undeveloped leasehold acreage and in identified producing wells in North America. In addition, Amplify Energy owns non-operated WIs in producing and undeveloped leasehold acreage.

Roughly 47 percent of the Company's estimated proved reserves as of December 31, 2016 were in the East Texas/Louisiana region. The Rockies was roughly 24 percent of its estimated proved reserves as of December 31, 2016.

Approximately 19 percent of Amplify Energy's estimated proved reserves as of December 31, 2016 were located offshore Southern California. Moreover, roughly 10 percent of its estimated proved reserves as of December 31, 2016 were located in South Texas.

Last month, Amplify Energy announced its operating and financial results for Q4 and full year 2018, year-end 2018 proved reserves, and provided guidance for Q1 and full year 2019. The Company announced 2019 Q1 and full year guidance that includes $37 million ($3 million invested during Q4 2018, $34 million in full year 2019) for the earlier announced capital project to boost oil production at its Bairoil field in the Rockies.

During Q4 this year, Amplify Energy generated Daily Production of 142.5 MMcfe/d. This was above the midpoint of quarterly guidance. It generated Net Cash Provided by Operating Activities of $25 million for the quarter, versus the guidance midpoint of $30 million.

Adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was $32 million. This was within the guidance range of $31 million to $37 million. Free Cash Flow of $18 million was within the guidance range of $16 million to $22 million.

Amplify Energy Corp. (AMPY), closed Friday's trading session at $6.80, up 4.06%, on 418 volume with 5 trades. The average volume for the last 3 months is 20,503 and the stock's 52-week low/high is $6.51/$11.50.

chart

CannaPharmaRX, Inc. (CPMD)

Hottest Stock Picks, Real Investment Advice, Stockaholics, Zacks, Infront Analytics, Capital Cube, Morningstar, Stockhouse, Barchart, The Street, Simply Wall St, GuruFocus, Insider Tracking, Daily Marijuana Observer, Stockopedia, Dividend Investors, The Seed Investor, PR Newswire, Marketwired, Seeking Alpha, InvestorsHub, Wallet Investor, Stockwatch, and 4-Traders reported beforehand on CannaPharmaRX, Inc. (CPMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Based in Irvine, California, CannaPharmaRX, Inc. focuses on the acquisition and development of state-of-the-art cannabis grow facilities located in Canada. The Company's business strategy is to become a leader in high quality and low-cost production of cannabis in Canada via the development, acquisition and enhancement of existing facilities. CannaPharmaRx's dedication is to operating high quality facilities employing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis. CannaPharmaRX lists on the OTC Markets.

The Company's corporate mission is to produce high quality, carbon footprint efficient pharmaceutical grade medical cannabis in ultramodern, highly efficient facilities in Canada for the distribution to wholesale licensed retailers across the nation. CannaPharmaRX's vision is the immediate national expansion via acquisitions for the continuing development of cannabis production facilities.

Recently, the Company completed an initial acquisition of a 48,500 square foot cannabis grow facility now under development. CannaPharmaRX is presently in discussions with other companies concerning potential acquisitions or business combinations. It is currently targeting acquisitions of companies in the final stages of obtaining cannabis licensee applications or those which are nearing revenue generation.

The Company's Hanover facility in the Province of Ontario includes 10 acres of land and a 48.8 thousand square foot growing space to produce 9.6 thousand kg of cannabis each year. Construction is underway and the projection is to complete by September of this year. CannaPharmaRX is projected to be licensed to cultivate, granted by Health Canada October 2019, and licensed to sell, granted by Health Canada December 2019; its sales will begin immediately.

This past January, CannaPharmaRX announced it completed the acquisition of Alternative Medical Solutions, Inc., (AMS), a Province of Ontario corporation. With this agreement, Hanover CPMD Acquisition Corp. (HCAC), a wholly-owned subsidiary of CannaPharmaRX, acquired all of the issued and outstanding securities of AMS for total consideration of CAD$12,710,000 comprising cash, common stock, and a promissory note. AMS is a late stage marijuana licensed producer applicant in Canada presently operating in the Pre-License Inspection and Licensing phase, which is Stage 5 of 6, with a fully approved license.

Recently, CannaPharmaRx announced it completed the acquisition of a minority interest in GN Ventures, LTD., (GNC), a Province of Alberta corporation, engaged in the development of Canadian cannabis cultivation facilities. With this stock purchase agreement, the Company acquired roughly 18 percent of the issued and outstanding securities of GNC for total consideration of 7,998,963 shares of CPMD common stock. The Company also acquired warrants exercisable to purchase an additional 2,500,000 shares of GN at an exercise price of CAD$1.00 per share. GNC owns a 60,000 square foot cannabis cultivation and grow facility situated on 38 acres in Stevensville, Ontario.

CannaPharmaRX, Inc. (CPMD), closed Friday's trading session at $2.00, up 17.65%, on 6,170 volume with 14 trades. The average volume for the last 3 months is 2,027 and the stock's 52-week low/high is $0.509/$4.00.

chart

CV Sciences, Inc. (CVSI)

Proactive Investors, MicroSmallCap, Equities, Zacks, Trading View, Barchart, Stockhouse, Tmxmoney, InvestorsHub, Stockwatch, Marketbeat, Wallet Investor, MarketWatch, Pot Stock News, Last10k, New Cannabis Ventures, Morningstar, 4-Traders, GuruFocus, CannabisMarketCap, Infront Analytics, Analyst Ratings, The Street, Simply Wall St, Daily Marijuana Observer, Ceo.ca, Insider Tracking, Insider Financial, and Streetwise Reports reported earlier on CV Sciences, Inc. (CVSI), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, CV Sciences, Inc. is a supplier and manufacturer of hemp CBD products. The Company operates two distinct business segments. One is a consumer product division centered on manufacturing, marketing and selling hemp-based CBD products to a range of market sectors. The other is a drug development division centered on developing and commercializing novel therapeutics using CBD. CV Sciences has main offices and facilities in San Diego, California and Las Vegas, Nevada.

CV Sciences' PlusCBD Oil is the top-selling brand of hemp-derived CBD on the market, according to SPINS, the foremost provider of syndicated data and insights for the natural, organic and specialty products industry. The Company's Pharmaceutical Division is developing synthetically‐formulated cannabidiol‐based medicine, pursuing the approval of the U.S. Food and Drug Administration (FDA) for drugs with specific indications using cannabidiol (CBD) as the active pharmaceutical ingredient.

The Company's Consumer Products Division delivers botanical‐based cannabidiol products. At present, these products are distributed nationally in health food stores, health care provider's offices, as well as online. All of CV Sciences' products are Non GMO, gluten-free, and tested to ensure the best quality CBD Oil available. The Company uses CO2 extraction and a chemical-free extraction process that is environmentally friendly and safe for all of its hemp CBD oil.

Last month, CV Sciences announced the appointment of Mr. Joerg Grasser as Chief Financial Officer (CFO), effective March 21, 2019. Mr. Grasser brings to his new role over two decades of experience and a wide-ranging background in accounting, finance, financial reporting and operations. He has served as Chief Accounting Officer of CV Sciences since December of 2018.

This week, CV Sciences announced further expansion of its PlusCBD Oil™. As of March 31, 2019, PlusCBD Oil™ branded products are available in 3,308 retail stores. This represents an increase of 48 percent from 2,238 retail stores as of December 31, 2018. The expansion includes increasing distribution of its best-selling topical, PlusCBD Oil™ Extra Strength Balm, into the Food, Drug and Mass (FDM) channel. This includes programs with top national retailers.

Recently, CV Sciences announced financial results for the year ended December 31, 2018. Fiscal 2018 Financial and Operating highlights include record Revenue of $48.2 million for 2018. This represents an increase of 133 percent over 2017. The Company had record Net Income of $10.0 million, or $0.09 per fully diluted share. Record adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) was $14.0 million or 29.0 percent of Net Revenue for 2018. This represents an increase of $12.4 million from $1.6 million for 2017.

CV Sciences, Inc. (CVSI), closed Friday's trading session at $5.89, up 7.09%, on 934,915 volume with 1,464 trades. The average volume for the last 3 months is 1,156,083 and the stock's 52-week low/high is $0.417/$9.19.

chart

Know Labs, Inc. (KNWN)

NetworkNewsWire, Tip Ranks, Last10k, Stockopedia, Dividend Investor, Marketbeat, Zacks, Simply Wall St, InvestorsHub, Equities, Corporate Information, Wallet Investor, Barchart, MarketWatch, Seeking Alpha, The Street, Insider Tracking, Stockhouse, Business Wire, and GuruFocus reported previously on Know Labs, Inc. (KNWN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Know Labs, Inc. is a provider of diagnostic solutions. The Company's technology directs structured light or radio waves through a substance or material to capture a unique molecular signature. Know Labs refers to these signatures as ChromaID™ and Bio-RFID™. The Company previously went by the name Visualant, Incorporated. It changed its name to Know Labs, Inc. in May of 2018. Know Labs has its corporate headquarters in Seattle, Washington.

ChromaID and Bio-RFID are used to identify, detect, or diagnose substance markers or biomarkers, which may be invisible to the human eye. ChromaID and Bio-RFID scanner modules can undergo integration into an array of wearable, mobile or bench-top form factors.

This patented and patent pending, award-winning technology makes it possible to effectively conduct analyses, which could only formerly be performed by invasive and/or large and expensive lab-based tests. ChromaID and Bio-RFID technologies use electromagnetic energy along the electromagnetic spectrum to perform analytics that enable the user to identify, authenticate, as well as diagnose materials and substances.

This past January, Know Labs released a white paper detailing the results of an experiment using the Company's Bio-RFID™ technology to detect differing blood-glucose levels in the human body. The experiment used a tissue phantom mimicking a blood/skin/muscle ratio of roughly 5 percent/10 percent/85 percent respectively to measure varying amounts of glucose in the blood. This experiment produced successful results with the sensor system showing strong signal response and linearity between the varying glucose levels.

In February, Know Labs released a video presentation of its Bio-RFID™ platform technology's successful identification of blood alcohol levels. In the video presentation, Chief Executive Officer, Mr. Phil Bosua discusses the Company's use of Bio-RFID to detect blood alcohol levels. He also discusses the wide-ranging implications for its technology platform.

The transcript of Mr. Bosua's presentation in the video states in part, "Over the last month we've been powering through a ton of experiments and innovations and are really happy to report we've now got an AI based algorithm that allows our technology to detect blood alcohol levels non-invasively. So it's official - Bio-RFID is now a platform technology. Not only can we detect the holy grail of biotech - blood glucose - but also - blood alcohol, and more to come in the future."

Know Labs, Inc. (KNWN), closed Friday's trading session at $1.39, up 2.96%, on 13,384 volume with 23 trades. The average volume for the last 3 months is 49,954 and the stock's 52-week low/high is $0.239/$5.75.

chart

Naked Brand Group Limited (NAKD)

Stock News Journal, Simply Wall St, The Street, Equities, Barchart, Stockopedia, Investing.com, Stock Invest, Stock Twits, Infront Analytics, Business Insider, 4-Traders, Investment Pitch, Zacks, Street Insider, Investor Place, InvestorsHub, and Stockhouse reported previously on Naked Brand Group Limited (NAKD), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Naked Brand Group Limited designs, manufactures, and sells men's and women's underwear, intimate apparel, loungewear, and sleepwear products. Its products are available in 44 countries through 6,000 retail doors, a growing network of E-commerce sites, and 61 company-owned Bendon retail and outlet stores in Australia and New Zealand. A unique fashion and lifestyle brand, Naked Brand Group has its corporate office in Alexandria, Australia.

Distinguished designer and sleepwear pioneer and Chief Executive Officer, Carole Hochman leads Naked Brand Group Limited. She joined the Company in 2014. Naked Brand Group's intention is to expand into more apparel and product categories that exemplify the mission of the brand. This includes activewear, swimwear, sportswear, and more.

Naked Brand Group and Bendon Limited, an international leader in intimate apparel and swimwear, announced in June of 2018 that they completed their business combination. With this Merger Agreement, Naked Brand Group and Bendon became wholly-owned subsidiaries of a newly created company, Bendon Group Holding Limited, which was renamed Naked Brand Group Limited (Holdco).

Naked Brand Group designs, manufactures, and markets a portfolio of 11 company-owned and licensed brands. These cater to a broad cross-section of consumers and market segments. The Company's brands include Naked, Bendon, Bendon Man, Davenport, Fayreform, Hickory, Lovable, Pleasure State, Heidi Klum Intimates, Heidi Klum Man, and Heidi Klum Swim.

Naked Brand Group Limited announced in November of 2018 that it closed its previously announced acquisition of the shares of FOH Online Corp. (FOH), the exclusive licensee of the Frederick's of Hollywood brand for worldwide e-commerce business. With the acquisition, Naked Brand Group will control FOH's exclusive license with the brand owner, Authentic Brands Group, which runs through 2020. It may be extended at FOH's option through 2070.

In the first half of Fiscal 2019, Naked Brand Group completed an agreement with CVS Health and launched the Heidi Klum Intimates Solutions line to more than 4,000 CVS locations throughout the U.S. The Company also launched a new Diffusion program nationwide with Costco Wholesale Australia and launched a retail and outlet store expansion strategy throughout Australia and New Zealand. Furthermore, it appointed veteran apparel executives to accelerate the fast growing e-commerce channel.

Naked Brand Group Limited (NAKD), closed Friday's trading session at $0.3172, up 2.95%, on 112,485 volume with 255 trades. The average volume for the last 3 months is 558,917 and the stock's 52-week low/high is $0.25/$11.36.

chart

Noble Roman's, Inc. (NROM)

Simply Wall St, Taglich Brothers, SmallCapVoice, Insider Financial, Marketbeat, The Bowser Report, Wallet Investor, FeedBlitz, Equity Clock, Penny Stock Tweets, Stockopedia Penny Stock Hub, Investor Village, Tip Ranks, Stock Oodles, Wall Street Resources, YCharts, and MicroCapClub reported earlier on Noble Roman's, Inc. (NROM), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Noble Roman's, Inc. sells and services franchises and licenses for non-traditional foodservice operations and stand-alone take-n-bake locations. The Company's business model consists of three growth venues. These are Grocery Take-n-Bake Licensing; Non-Traditional Franchising; and Stand-Alone Franchising. The Company franchises and licenses under the Noble Roman's Pizza, Noble Roman's Take-N-Bake, Tuscano's Italian Style Subs, and Noble Roman's Craft Pizza & Pub (CPP) trade names. Noble Roman's is headquartered Indianapolis, Indiana.

The Company has awarded franchise and/or license agreements in all 50 U.S. States plus Washington, D.C. In addition, Noble Roman's has awarded franchise and/or license agreements in Canada, Puerto Rico, the Bahamas, Italy, and the Dominican Republic.

Concerning the Company's three growth venues,  Grocery Take-n-Bake Licensing involves licensing to sell Noble Roman's Pizza. This is a component program using Noble Roman's ingredients, in which delis assemble pizzas from standard Noble Roman's ingredients.

Pertaining to Stand-Alone Venues, these are traditional pizzeria locations and Take-n-Bake locations. There is a merging over time between the kinds of Stand-Alone Venues: Live Yeast Dough; Hand-Rolled Breadsticks; and Baking Services.

Regarding Non-Traditional Venues, these are typically located in a host facility whose chief business is other than foodservice. These facilities can add pizza-focused foodservice as a Revenue Center; as a Facility Draw; and as an Employee Benefit.

On January 31, 2017, the first Noble Roman's Craft Pizza & Pub (CPP) opened in Westfield, Indiana. In May of 2018, the Company announced that it opened a fourth location of its new-generation, stand-alone pizzeria concept, Noble Roman's Craft Pizza & Pub (CPP) in Carmel, Indiana.

Noble Roman's intention is to expedite the development of Craft Pizza & Pub (CPP) locations via franchising. General franchising is planned for Indiana and surrounding areas with an emphasis on franchisees that can become multi-unit operators. Moreover, the Company will also pursue development of other markets deemed suitable for the concept with experienced multi-unit operators.

In January, Noble Roman's announced that it completed the roll-out of its new curbside carry-out service in all restaurant locations. The design of the Company's new curbside service for carry-out customers is to create added value and convenience. The program is called "Pizza Valet Service." With Pizza Valet Service, customers place orders ahead, drive into the restaurant's reserved valet parking spaces, and have their pizza run to their vehicle by specially uniformed pizza valets.

Additionally, in January, Noble Roman's announced that its first franchisees for Craft Pizza & Pub (CPP), Patrick and Holly O'Neil, signed a lease and entered into a construction contract for their first CPP restaurant in Lafayette, Indiana. Construction is now taking place. This location is scheduled for a grand opening by late March.

Noble Roman's, Inc. (NROM), closed Friday's trading session at $0.44, up 2.33%, on 15,000 volume with 6 trades. The average volume for the last 3 months is 10,283 and the stock's 52-week low/high is $0.33/$0.75.

chart

Hut 8 Mining Corp. (HUTMF)

Stockhouse, Wallet Investor, Morningstar, SmallCapVoice, Business Insider, MarketWatch, YCharts, Blockchain Stocks, Universal Crypto News, 4-Traders, otc.watch, TradingView, Market Screener, The Street, InvestorsHub, Stockwatch, GuruFocus, and Seeking Alpha reported on Hut 8 Mining Corp. (HUTMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Hut 8 Mining Corp. is one of the world's largest public cryptocurrency mining companies by operating capacity and market capitalization. The Company formed through an exclusive arrangement with the Bitfury Group, the world's foremost full-service blockchain technology company. Hut 8 Mining has its head office in Toronto, Ontario. The Company lists on the OTC Markets Group's OTCQX.

Since commencing its mining operations in December of 2017, Hut 8 has mined more than 5,600 bitcoins. In total, Hut 8 owns and operates two sites in Alberta, Canada using 85 BlockBox AC data centers.

Via the Bitfury Group, Hut 8 has access to a world-leading proprietary mix of hardware, software and operational expertise to construct, optimize and manage data centers in low-cost and attractive jurisdictions. Hut 8's intention is to provide investors with exposure to blockchain processing infrastructure and technology along with underlying cryptocurrency rewards and transaction fees.

The Company provides investors with direct exposure to bitcoin without the technical complexity or constraints of purchasing the underlying cryptocurrency. Investors circumvent the need to create online wallets, wire money offshore, and safely store their bitcoin.

Hut 8 successfully completed the purchase of 12 additional BlockBox AC data centers from Bitfury® this past December. The new BlockBox AC data centers use the Bitfury Clarke ASIC chips, manufactured by Bitfury. Hut 8 notes that the performance of these new data centers has surpassed expectations by producing 12.2 Petahash per second (PH/s) per BlockBox AC data center but consuming roughly 1.1 MW of electricity instead of the 12 PH/s and 1.2 MWs expected before installation.

Moreover, Hut 8's 85 BlockBox AC data centers ( because of electricity optimization across its sites) are consuming, on average, 1.12 MWs each, while still producing an aggregate output of about 784 PH/s. Therefore, the Company's present collective operating electrical consumption is around 95.2 MWs, instead of the previously expected 100.2 MWs of consumption, across its 85 Blockbox AC data centers.

Hut 8 Mining Corp. (HUTMF), closed Friday's trading session at $1.0567, up 10.65%, on 12,400 volume with 21 trades. The average volume for the last 3 months is 10,357 and the stock's 52-week low/high is $0.599/$3.504.

chart

Kraken Robotics, Inc. (KRKNF)

Spotlight Growth, Ocean News, Stockwatch, Wallet Investor, InvestorsHub, Marine Technology News, OTC Markets, 4-Traders, Barchart, Electric Energy Online, Morningstar, Stockhouse, InvestorsHangout, TradingView, Market Screener, MarketWatch, Seeking Alpha, and GuruFocus reported earlier on Kraken Robotics, Inc. (KRKNF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Kraken Robotics, Inc.'s commitment is to the production and sale of software, sensors, and robotic systems for the international Unmanned Maritime Vehicles market. The Company's wholly-owned subsidiary is Kraken Robotic Systems, Inc. A marine technology enterprise, Kraken Robotics is based in St. John's, NL (Newfoundland and Labrador). The Company also has offices in Dartmouth, Nova Scotia; Bremen, Germany; and Fairfax, Virginia. Kraken Robotics lists on the OTC Markets' OTCQB.

The Company's wholly-owned subsidiary, Kraken Robotic Systems, Inc., is developing an ultra-wideband acoustic remote sensing system for seafloor imaging and mapping. The AquaPix® Multispectral Synthetic Aperture Sonar (SAS) will be the world's first commercial SAS to operate over such a wide spectrum, ranging from low audible frequencies to high ultrasonic frequencies.

Kraken Robotics' series of SAS (Synthetic Aperture Sonar) products named AquaPix® take advantage of almost 20 years of research and development (R&D) conducted by NATO's Undersea Research Centre and millions of dollars in funding support from NATO government sponsors. AquaPix® provides comparable performance to existing high end military systems at a reduced cost.

AquaPix® can provide detailed seabed images with a constant resolution better than 3cm x 3cm out to a range of 300m from each side of an underwater vehicle (600m swath). It can also produce 3D bathymetric data with a resolution better than 25cm x 25cm out to full range. This is while delivering very high depth accuracy, in compliance with IHO S44 special order requirements.

Furthermore, Kraken Robotics has its DataPod™ product. The design of it is to meet modern data storage requirements for rugged marine applications. DataPod™ combines the user-friendliness of a Network Attached Storage system with the reliability of a RAID array and solid-state storage all in one compact unit. Kraken also has its Kraken SeaVision™ system. This is an inventive new take on subsea 3D laser imaging. The design of it is to operate in a twin scanning configuration, with adjustable baseline. SeaVision can produce very high resolution 3D scans in full color.

Kraken Robotics has expanded from sensors to complete systems. It has introduced its KATFISH™ tethered underwater vehicle. The Company has also introduced the THUNDERFISH® autonomous underwater vehicle (AUV).  It also has its AQUATRAK® CVL product. This speed sensor is a derivative of its SAS technology and is for the oil and gas sector for ROVs.

In January, Kraken Robotics announced that it completed the majority acquisition of Kraken Power GmbH. Via the conversion of an existing note receivable to equity and a cash payment of roughly €0.1 million, Kraken increased its ownership in Kraken Power GmbH to 75 percent. Kraken Power GmbH (Rostock, Germany) employs a 20-person team consisting of highly skilled engineers, technicians and administration staff.

Today, Kraken Robotics announced that its wholly-owned subsidiary, Kraken Robotic Systems, Inc., received purchase orders for about $1.7 million from Ocean Infinity for Kraken's AquaPix® Synthetic Aperture Sonar (SAS) sensors and support. This is the second set of purchase orders from Ocean Infinity under an initial master agreement contract announced in Q3 of 2017.

Kraken Robotics, Inc. (KRKNF), closed Friday's trading session at $0.611, up 1.36%, on 82,304 volume with 23 trades. The average volume for the last 3 months is 63,824 and the stock's 52-week low/high is $0.10644/$0.6934.

chart

American Lithium Corp. (LIACF)

Analysts Buzz, Stock Orange, Geology for Investors, Energy and Capital, Wallet Investor, Junior Mining Network, OTC Markets, MarketWatch, Stockhouse, TradingView, InvestorsHub, Investors Hangout, Barchart, Barron's, Stockwatch, The Street, Dividend Investor, Market Screener, Wallmine, GuruFocus, Stock News Oracle, and Marketing Minerals reported earlier on American Lithium Corp. (LIACF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.

American Lithium Corp. engages in the acquisition, exploration, and development of lithium deposits within mining-friendly jurisdictions across the Americas. The Company's Fish Lake Valley lithium brine properties are around 38 kilometers from Albemarle's Silver Peak (the largest lithium producer in the U.S.). OTCQB-listed, American Lithium has its head office in Vancouver, British Columbia.

The Company holds options to acquire Nevada lithium brine claims totaling 22,332 acres (9,038 hectares). This includes 18,552 contiguous acres (7,508 hectares) in Fish Lake Valley, Esmeralda County; and the 2,240-acre (907-hectare) San Emidio project in Washoe County.

Fish Lake Valley is one of the most promising and largely undeveloped lithium brine basins in Nevada. Its geological and geophysical characteristics are akin to the Clayton Valley basin situated to the southeast. The Fish Lake Valley land package acquisition includes the North and South Bowl Playas. This acquisition covers all vital structures of the North and South Bowl Playas, which contain the lithium brines, and where gravity data shows distinct gravity lows.

American Lithium is expanding its existing holdings in Fish Lake Valley, Esmeralda County. The Company is already the main land holder in the Valley, with 18,552 contiguous acres under management. American Lithium previously entered into an agreement to acquire an additional 3,575-acre parcel in the Valley, comprising 167 contiguous claims called the Gap-Lode Project. This Project overlies 2,480 acres of public land. The Gap-Lode Project is adjacent to an existing 1,094-acre claim block.

The San Emidio Project is 60 miles (100 km) northeast of Reno - home to Tesla's Gigafactory. Lithium concentrations in brines at San Emidio are reasonably expected to increase at depth. This is also the case at Clayton Valley. A gravity geophysical survey indicates a previously discovered near surface lithium brine anomaly on the west side of basinal low. Anomalous lithium values were detected during brine sampling. The highest value was 80 mg/L.

Last week, American Lithium reported that it engaged Harris Exploration Drilling and Associates, Inc., of Fallon Nevada, to begin drilling on its 630 ha (1,550 acre), TLC lithium claystone project situated minutes from the mining center of Tonopah, Nevada.

The wholly-owned Tonopah Lithium Claystone (TLC) Project is scheduled for 1,600 m (5,000 feet) of 5.5" diameter reverse circulation drill sampling to increase the scope and subsequent valuation of this prospective lithium-bearing claystone-rich environment. Twenty-two (22) grab samples were previously analyzed returning grades ranging from 129.5 to 1380 parts per million (ppm) lithium (Li) with an average grade of 656.5 ppm Li.

Mr. Mike Kobler, American Lithium Chief Executive Officer, said, "With this drilling program, we look forward to determining the depth extension of the regional lithium claystone target which we believe holds great promise as this particular mineralization could represent a highly economically advantageous and game-changing extraction opportunity poised to meet the inevitable resurgence and growth of the domestic lithium resource sector in Nevada."

American Lithium Corp. (LIACF), closed Friday's trading session at $0.31, down 0.70%, on 73,959 volume with 45 trades. The average volume for the last 3 months is 242,873 and the stock's 52-week low/high is $0.1753/$0.6256.

chart

Biotricity, Inc. (BTCY)

SmallCap Network, MarketWatch, Insider Financial, Stockhouse, Stock News Now, InvestorsHub, GuruFocus, 4-Traders, Morningstar, Finance Registrar, Barchart, The Street, Stockwatch,  SECFilings.com News, and Stockopedia reported beforehand on Biotricity, Inc. (BTCY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Biotricity, Inc. is a medical diagnostic and consumer healthcare technology company headquartered in Redwood City, California. Its dedication is to deliver biometric remote monitoring solutions. The Company delivers these solutions to the medical and consumer markets. This includes diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity's vision is putting health management into the hands of the individual. The Company was named Best Remote Patient Monitoring Solution by MedTech Breakthrough on June 6, 2018. Biotricity lists on the OTC Markets Group's OTCQB.

  Biotricity is working to support the self-management of critical and chronic conditions with the use of unique solutions to ease the increasing burden on the healthcare system. The Company's Research and Development (R&D) continues to focus on the preventative healthcare market.

Biotricity has created two ECG monitoring devices. The design of these is to improve upon the tools and devices available in the present-day market. For Consumers, the Company has its Biolife. This is a preventative care solution that takes advantage of the expertise gained from the Company's Bioflux described below. The design of Biolife is to help individuals in tracking their progress in real-time so they can stay motivated to make lifestyle changes. Biolife helps users make lifestyle changes through uniting medically relevant ECG data with social media interactivity and a lifestyle log. 

For Physicians, Biotricity has the above-mentioned Bioflux. This is a medical technology solution for physicians to test and diagnose patients, and benefit from an innovative system that provides ongoing active monitoring for up to 30 consecutive days.

Bioflux comprises an ECG monitoring device, software, and access to a monitoring lab. The Bioflux software component is an acquisition that is already Food and Drug Administration (FDA) cleared. It is a standard for ECG monitoring in hospitals and cardiac clinics. 

The Company is continuing to develop "Biopatch," an ECG patch that it expects filing with the FDA by Q1 2019. Biopatch is an extension of Biotricity's award-winning Bioflux device. Biopatch offers an alternative to the 3-lead system that is ideal for patients with less complicated cardiac conditions. The patch leverages the capabilities of Bioflux. It provides wireless arrhythmia monitoring for patients who are either at risk for, or diagnosed with, certain cardiac issues.

Last month, Biotricity provided an end of year update to its shareholders. Biotricity experienced a 211 percent growth in sales from Q2 2018 to Q3 2018. Furthermore, new device placements increased 182 percent from Q2 2018 to Q3 2018. The Company expects this sales growth to continue as the technology is introduced into additional territories in the U.S. Biotricity is currently concentrating on the growth of its commercial organization, sales growth, market expansion, and the development of new product applications this year.

Biotricity, Inc. (BTCY), closed Friday's trading session at $0.86, down 2.27%, on 17,600 volume with 14 trades. The average volume for the last 3 months is 83,824 and the stock's 52-week low/high is $0.422/$4.96.

chart

ZIVO Bioscience, Inc. (ZIVO)

Wallet Investor, Pink Investing, StockInvest.us, Zacks, Equity Clock, OTC Markets, RedChip, Marketbeat, Street Insider, Business Insider, Ceocast News, MarketWatch, Marketwired, and Stockhouse reported previously on ZIVO Bioscience, Inc. (ZIVO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

ZIVO Bioscience, Inc.'s commitment is to the development and commercialization of nutritional compounds and bioactive molecules derived from its proprietary algal strains. ZIVO also engages in the development of natural bioactive compounds for use as dietary supplements and food ingredients, and biologically derived and synthetic candidates for medicinal and pharmaceutical applications in humans and animals, specifically focused on autoimmune and inflammatory response modulation. OTCQB-listed, ZIVO Bioscience has its corporate headquarters in Keego Harbor, Michigan. The Company's wholly-owned subsidiary is WellMetris, LLC.

ZIVO Bioscience is a biotech/agtech R&D company re-inventing itself as a licensor of internally developed intellectual property (IP) that includes its proprietary algae cultures, in addition to IP secured via strategic acquisitions. The Company works to completely harness the beneficial effects of its natural bioactive agents and make them affordable and readily available in a useful and convenient form.

More recently, ZIVO has continued to focus almost exclusively on dairy cow applications for its proprietary algal biomass, extracts and any high-value bioactive compounds thereof. This is while developing the business case and production scale-up to cultivate and productize the algal biomass.

The Company's core IP consists of the algae culture itself, the patented process of producing that culture, and the bioactive compounds or molecules that can be extracted, and also the application of that culture or extract in supporting health maintenance and longevity. ZIVO's plan is to approach the near-term markets first - animal applications, human food ingredients, as well as human dietary supplements.

This past December, ZIVO Bioscience announced that preliminary data analysis from its most recent poultry nutritional efficacy study show positive results that confirm the successes of prior poultry efficacy studies conducted in partnership with NutriQuest, an international innovator in animal nutrition. The 5,000-bird study confirms that pelleted feed containing ZIVO algal biomass consumed in sufficient quantity results in birds exhibiting improved health indicators.

Recently, ZIVO Bioscience announced the issuance of US patent No. 10,161,928 - Wellness Panel - on December 25, 2018. The patent describes the novel use of urinary biomarkers to measure metabolic efficiency and vitality, rather than attempting to use standard medical diagnostics to measure healthiness.

ZIVO Bioscience, Inc. (ZIVO), closed Friday's trading session at $0.11, down 8.33%, on 48,050 volume with 9 trades. The average volume for the last 3 months is 64,388 and the stock's 52-week low/high is $0.002/$0.189.

chart

The QualityStocks Company Corner

Youngevity International, Inc. (NASDAQ: YGYI)

The QualityStocks Daily Newsletter would like to spotlight Youngevity International, Inc. (YGYI).

Khrysos Industries, a subsidiary of leading omni-direct lifestyle company Youngevity International (NASDAQ: YGYI), recently acquired 45 acres of land for research and development. To view the full article, visit: http://nnw.fm/2ojMC.

Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.

Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.

Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.

Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.

Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:

  • Health and Nutrition
  • Home and Family
  • Food and Beverage
  • Spa and Beauty
  • Fashion
  • Essential Oils
  • Photo and scrapbooking
  • Services for Home and Business

Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.

Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.

Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $5.45, up 0.18%, on 54,321 volume with 400 trades. The average volume for the last 3 months is 209,175 and the stock's 52-week low/high is $3.167/$16.25.

Recent News

chart

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade, Inc. (OTCQB: SGMD), a major supplier to the growing hydroponic cultivation sector, today announces the signing of a supply contract with Hempistry, Inc. where the Kentucky-based hemp cultivator is acquiring supplies for its hemp micropropagation operation.  Sugarmade expects this supply relationship to be ongoing as Hempistry expands its operations, both domestically and internationally.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed the day's trading session at $0.05, up 3.63%, on 1,427,840 volume with 109 trades. The average volume for the last 3 months is 1,305,987 and the stock's 52-week low/high is $0.0425/$0.209.

Recent News

chart

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF)

The QualityStocks Daily Newsletter would like to spotlight FinCanna Capital Corp. (FNNZF).

Royalty company for the U.S. licensed medical cannabis industry FinCanna Capital (CSE: CALI) (OTCQB: FNNZF) today announced its appointment of Harborside's wholesale and distribution manager Dani Walton to its board of advisors. To view the full press release, visit: http://nnw.fm/qL6oI.

FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) is a royalty company aiming to be the capital partner of choice for high-growth, best-in-class businesses operating in the licensed U.S. medical cannabis industry. Primarily focused on the burgeoning California cannabis market, FinCanna leverages extensive investment expertise and industry experience to benefit its shareholders and portfolio companies.

Medical Cannabis Market

According to Ameri Research, the global market for licensed medical cannabis is growing at a compound annual growth rate (CAGR) of more than 21%, on track to exceed $63.5 billion by 2024. Within this market, FinCanna has identified considerable opportunity in California, the fifth largest economy in the world and the largest medical cannabis market in North America. Arcview Group forecasts California’s legal cannabis industry will grow at 21.1% CAGR to $6.5 billion in 2020, generating more than $1 billion in tax revenue.

Royalty Model & Portfolio

FinCanna’s “whole capital” solution for businesses in the licensed medical cannabis sector includes the provision of capital investment for a percentage of their future revenues. The FinCanna Capital Solution utilizes a royalty arrangement to deliver capital, in order to facilitate the growth or other specific objectives of its investees, and ensure the business opportunity is optimized. This model provides an alternative or complement to debt and equity financing, allowing investees to maintain financial flexibility and control of their business rather than entering into arrangements that may include restrictive debt structures or giving up an ownership stake.

FinCanna’s portfolio includes Cultivation Technologies, Inc. (“CTI”), a team of experts from Fortune 150 agriculture, medical cannabis, law, engineering and technology companies. FinCanna is providing funding to CTI for its planned, fully entitled, large-scale indoor medical cannabis facility to be developed in Coachella, California.

CTI has established an interim medical cannabis extraction facility (the “Interim Facility”) that will produce licensed medical cannabis products until the Coachella Project is complete. CTI is currently expanding its product line, Coachella Premium, to include vaporizer cartridges. Initial market feedback gathered during the product development phase indicates that Coachella Premium’s vaporizer cartridges offer a unique proposition within the vaporizer market, one of the fastest growing verticals in the cannabis market.

The Interim Facility can process up to 6,000 pounds of biomass per month, the equivalent of approximately 3.7 million grams of raw oil per year, with room for expansion. It is expected that the completed Coachella Project will be able to process 30,000 to 50,000 pounds of biomass per month, or the equivalent of 18 million grams to 30 million grams of raw oil per year.

Additionally FinCanna has entered into a royalty agreement with Green Compliance, a provider of point-of-sale software solution (“ezGreen”) for licensed medical cannabis dispensaries and cultivators. Green Compliance helps its customers comply with both the Health Insurance Portability and Accountability Act (“HIPAA”) and State Laws by ensuring patients’ confidential data is being handled properly, helping to protect from possible security breaches and financial and criminal liability resulting from potential violations.

FinCanna has also signed binding term sheet with Oakland, California-based Gram Co Holdings, subject to due diligence by FinCanna. Gram Co is a cannabinoid research and refinement facility focused providing B2B and B2C products and services to licensed medical dispensaries, infused product manufacturers, and numerous others in the cannabis supply chain. The company is also retrofitting a large, state-of-the-art medical cannabis extraction laboratory, which is expected to be operating in 2018.

The foregoing contains forward-looking statements regarding Cultivation Technologies Inc. (“CTI”) which are subject to risks, uncertainties and contingencies which include, but are not limited to the statements relating the future construction and completion of the CTI medical cannabis facility in Coachella, California, and the projected biomass processing and raw oil production at the facility. Such forward looking statements are based on assumptions regarding the construction, completion and operations of CTI’s proposed facility, including that CTI will obtain the financing required to build and equip its proposed facility, that CTI will obtain the additional financing required operate the facility, that construction facility is completed on time and budget, that CTI obtains state licenses to operate on a permanent basis, and that the equipment used in the cultivation of medical cannabis performs at scale in a similar way it performs at CTI’s pilot tests.

FinCanna Capital Corp. (FNNZF), closed the day's trading session at $0.107, up 0.38%, on 14,269 volume with 10 trades. The average volume for the last 3 months is 32,254 and the stock's 52-week low/high is $0.0577/$0.50.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

Financial results show that 2018 was a successful year of growth for Trxade Group Inc. (OTCQB: TRXD), an integrated drug purchasing and delivery solutions company with a platform that enhances supply chain efficiencies among health care buyers and sellers of pharmaceuticals, accessories and services. The company recently presented its report for the final quarter of 2018, highlighting a number of key accomplishments (http://nnw.fm/Dq3JZ).

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed the day's trading session at $0.45, off by 16.67%, on 10,020 volume with 3 trades. The average volume for the last 3 months is 1,861 and the stock's 52-week low/high is $0.23/$1.00.

Recent News

chart

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF)

The QualityStocks Daily Newsletter would like to spotlight Plus Products Inc. (CSE: PLUS) (OTC: PLPRF).

Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) was highlighted today in a publication from Financialnewsmedia.com, examining how 2019 will be a year of maturation and expansion for the cannabis industry.

Plus Products Inc. (CSE: PLUS) (OTC: PLPRF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.

First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.

PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.

Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.

During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:

  • Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
  • Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
  • Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
  • Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
  • Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
  • Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.

“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”

The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.

Plus Products Inc. (PLPRF), closed the day's trading session at $3.78, off by 1.24%, on 52,999 volume with 133 trades. The average volume for the last 3 months is 83,638 and the stock's 52-week low/high is $2.81/$6.008.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood, Inc. (OTCQB: NGTF), the innovative company solving America's $50 billion-dollar nighttime snacking problem, announced today that CEO Sean Folkson has been invited to speak at the 13th Annual Global Dairy Congress in Lisbon, Portugal the week of June 24.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed the day's trading session at $0.68, off by 2.86%, on 212,289 volume with 84 trades. The average volume for the last 3 months is 553,433 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (NASDAQ:GNPX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company for private and public entities. To view the full publication, titled "Potential Blockbuster Gene Therapy Programs to Watch in 2019," visit: http://nnw.fm/YC9iq.

Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed the day's trading session at $1.82, up 1.11%, 19,152 volume with 53 trades. The average volume for the last 3 months is 49,480 and the stock's 52-week low/high is $0.16/$0.92.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) was highlighted today in a publication from Financialnewsmedia.com, examining how, in recent industry reports, China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ($1.0 billion), Europe ($980 million) and South and Central America ($220 million).

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $3.152, up 1.03%, on 606,145 volume with 884 trades. The average volume for the last 3 months is 1,408,401 and the stock's 52-week low/high is $1.607/$7.894.

Recent News

chart

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF)

The QualityStocks Daily Newsletter would like to spotlight Supreme Cannabis Company Inc. (OTC: SPRWF).

Supreme Cannabis Company's (TSX.V: FIRE) (OTCQX: SPRWF) (FRA: 53S1) 7ACRES subsidiary is expanding its cultivation facility space. The expansion is set to increase its production capacity by 50%, reaching approximately 26,250 kg. To view the full article, visit: http://nnw.fm/x4WhD. Also today, the company was highlighted in a publication from Financialnewsmedia.com, examining how, in recent industry reports, China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ($1.0 billion), Europe ($980 million) and South and Central America ($220 million).

Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF), is committed to providing premium brands and products that reflect the company’s knowledgeable customers, passionate employees, and culture of innovation. Supreme Cannabis’ mission is to grow the world’s best cannabis and become a leader in the global industry. The company calls its Toronto Venture Exchange stock symbol FIRE “a testament to our passion for cannabis and our obsession with quality.”

Supreme Cannabis believes the world is ready to follow Canada’s lead by ending the 100-year cannabis prohibition and, as Canada’s only coast-to-coast premium cannabis producer, the company sees itself at the center of this global shift.

In August 2018, Supreme Cannabis uplisted its shares to the to OTCQX market in the U.S., where the company trades under the ticker symbol SPRWF. The following month Supreme reported record Q4 revenues of CAD$3.55 million, a 71-percent increase over the previous quarter. Supreme Cannabis also recorded revenue of CAD$8.85 million for its fiscal year ended June 30, 2018, placing it among publicly traded Canadian cannabis companies with the highest reported revenue in their first four quarters of sales.

“As a result of the successful execution of our strategy, we have generated significant revenue growth both for the quarter and the year-end period,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release. “We look forward to building on this growth as we expand domestically and internationally.”

The company’s growth strategy includes key industry agreements, such as its CAD$12 million supply agreement with Tilray Inc. (OTC: TLRY), a global leader in cannabis research, cultivation, processing and distribution. The agreement calls for Supreme to supply Tilray with dried cannabis for support of medical cannabis patients in Canada for the period of one year.

Another key component is the company’s wholly owned 7ACRES subsidiary. The 7ACRES cultivation facility, one of the first 40 federally licensed cannabis producers in Canada, is focused on building a core competency in scaled cannabis production, which will give 7ACRES the needed flexibility to maintain leadership in the industry as the Canadian market grows and matures. Though 7ACRES is Supreme Cannabis’ flagship brand and only currently operating business unit, the company will continue to identify new opportunities to grow its portfolio of companies and build innovative cannabis businesses throughout the world.

7ACRES operates from a 342,000-square-foot cultivation facility in Kincardine, Ontario, and has been federally licensed since 2016. Current capacity is 13,333 kilograms dried cannabis annually, with plans to ramp up production by mid-2019 to a rate of 50,000 kilograms per year.

Supreme Cannabis seeks to differentiate 7ACRES from other licensed cannabis producers by producing premium quality product sustainably at scale. “Craft quality, commercial scale” is a slogan the company uses, and the Kincardine greenhouse employs state-of-the-art technology and cultivation best practices to strive toward that goal. Supreme identifies the quality of the 7ACRES product as the company’s primary strength and says a shared “passion for the plant” is the driver of company culture. Six Canadian provinces have signed supply agreements with Supreme, a fact the company credits to the high quality of 7ACRES cannabis.

Its customers, Supreme Cannabis management says, are informed and discerning regarding cannabis, and they value a premium brand that respects their product knowledge. The company believes its high regard for customers, premium product quality, and mass cultivation capability has allowed Supreme Cannabis to emerge as Canada’s preeminent premium cannabis producer. In the Canadian cannabis market, the company has established 7ACRES as a premium brand that’s distributed coast-to-coast and commands premium pricing. The 7ACRES brand is already listed as premium cannabis product in all provinces that disclose their cannabis listing categories, and 7ACRES on average wholesales for up to one-third higher in price than other brands in the Canadian cannabis market.

To further its distribution, in the medical cannabis market Supreme Cannabis has partnered with several Canadian cannabis retailers including Aurora Cannabis, Emerald Health Botanicals, Namaste, Zenabis, and others. The company’s investment portfolio also includes an equity position and long-term global distribution partnership with Medigrow, based in Lesotho, targeting the export of medical cannabis oil for the international market.

Supreme Cannabis seeks to make the company an innovator in the cannabis sector regarding design of cultivation facilities and development of operation excellence metrics. The management team is confident that the 7ACRES flagship brand, the company’s proprietary technology and products, and the company’s culture of passion for cannabis will deliver consistent long-term shareholder value.

Supreme Cannabis Company Inc. (OTC: SPRWF), closed the day's trading session at $1.505, up 2.41%, on 483,944 volume with 554 trades. The average volume for the last 3 months is 683,414 and the stock's 52-week low/high is $0.85/$2.04.

Recent News

chart

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8)

The QualityStocks Daily Newsletter would like to spotlight Kontrol Energy Corp. (CSE: KNR).

Efforts to "save the planet" have for decades turned worries about changes in our natural environment into a variety of climate-friendly endeavors, once leading comedian George Carlin to complain, "Save the planet?! We don't even know how to take care of ourselves yet!" Smart energy efficiency platform developer Kontrol Energy Corp. (CSE: KNR) (OTCQB: KNRLF) (FSE: 1K8) is helping businesses take care of themselves and care for their neighbors while making the earth's climate a little friendlier for humanity in the process.

Kontrol Energy Corp. (CSE: KNR) (OTC: KNRLF) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.

Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.

As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.

Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.

Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.

Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:

  • Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
  • Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
  • Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
  • Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
  • Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.

The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.

The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.

Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.

Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.87, off by 2.25%, on 10,350 volume with 10 trades. The average volume for the last 3 months is 37,170 and the stock's 52-week low/high is $0.46/$0.99.

Recent News

chart

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF)

The QualityStocks Daily Newsletter would like to spotlight Wildflower Brands Inc. (WLDFF).

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) on Tuesday announced its entry into a non-binding letter of intent ("LOI"), dated April 3, 2019, to acquire City Cannabis Corp. in exchange for common shares of Wildflower. To view the full press release, visit: http://nnw.fm/W6WPj. Also today, the company was featured today in the 420 with CNW by CannabisNewsWire. Additionally, CannabisNewsWire released a report featuring the company which examines the recent news that the CBD market is experiencing explosive growth as a result of growing mainstream acceptance and strong leadership.

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) is a public cannabis company developing and designing brands that focus on plant-based wellness and health products. Wildflower markets its full-spectrum CBD products to retailers in the health and wellness space throughout the United States and in legal cannabis markets in accordance with regulations marketing its THC and CBD products.

Headquartered in Vancouver, British Columbia, Canada, Wildflower employs a unique and holistic business model that encompasses research and development, manufacturing, distribution, marketing and retail. First launched in 2012 as a private company with a cannabis-focused brand, Wildflower went public in 2014 and has since reached numerous significant milestones in its drive to create brands that work in synergy toward becoming a global wellness brand leader.

Gathered within the growing family of Wildflower brands are the following entities:

  • Wildflower Wellness is known for its reputable brand, uncompromising quality and mission to connect people with the healing power of plants. Wildflower Wellness offers CBD vaporizers, capsules, tinctures, soaps and topicals that are backed by a 100 percent satisfaction guarantee. Wildflower Wellness offers a full lineup of full spectrum CBD extract infused products made in the U.S. in Wildflower’s GMP facilities which are always third-party lab tested for quality assurance and accurate labeling.
  • King Extracts is a California-based company focused on cannabis technology and delivery systems. The King Recharge is a discreet, 97mm small, rechargeable vaporizer with a sleek pocket-sized charging and storage case. King concentrates are clean and sophisticated blends made from CO2 extractions that are fractionally distilled for clarity and purity with proprietary terpenes blended in to deliver a robust, full-flavor profile. King products are available at 26 select, regulated retail dispensaries in California.
  • Exclusive is a dispensary of high-quality cannabis products and accessories serving the city of Los Angeles, California. The company enjoys a close association with select hospital oncology departments and community programs.

Using the slogan “Plants Heal,” Wildflower’s distribution network in the U.S. includes 200+ retailers in Washington state and 20+ retailers in New York City. Wildflower has also partnered with Retail Worx to establish shop-in-shop retail locations in the heart of New York City which pairs nicely with the introduction of Wildflower into existing Bridges General’s stores in New York City and San Francisco. Through this partnership with Retail Worx, Wildflower by Bridges General stores will have exclusive product offerings in addition to the full lineup of existing Wildflower Wellness CBD products. Distribution in other U.S. markets includes 80+ wellness and healthcare practitioners with a total distribution of over 300 stores nationwide.

Wildflower holds 14 California cannabis licenses that cover recreational and medical cannabis cultivation, manufacturing, distribution and retail/delivery in the jurisdictions of California state and the city of Los Angeles. Opportunities to activate these licenses creates the phenomenal potential of driving significant revenues while minimizing risk. Expansion plans into Canada are underway with discussions centered on retail acquisitions and Wildflower launching into over-the-counter market with its CBD product line. Global expansion is a key part of Wildflower’s strategy with initial plans aimed at specific international markets where regulatory hurdles are less restrictive.

In December 2018, Wildflower began on-demand, legal and licensed cannabis delivery services to adult consumers in the Los Angeles area and has hired dozens of full-time delivery drivers to accommodate this unmet need. Wildflower has partnered with leading technology and logistics company Eaze.com to help route deliveries efficiently, manage inventory and comply with California law. Providing legal, licensed delivery services helps to ensure that all adults including those with mobility challenges and limited access to transportation services can purchase high quality, legal cannabis products.

Wildflower’s direct-to-consumer online store sales have shown an organic growth. The Company recently achieved over 300 percent growth in online sales since January 2018 with annualized revenues exceeding $1 million for online sales only, marking the ninth consecutive quarter of increased revenue.

Core Team

William MacLean is the founder and CEO of Wildflower Brands Inc. His involvement in all aspects of the business from product R&D to manufacturing setup has led the Company to its current success. MacLean is a seasoned sales professional with over 20 years of experience in various industries from advertising and marketing to medical sales. While in the advertising and marketing space, his clients included major brands including: Bell, Remax, BC Hydro, and Royal Bank.

CFO Stephen Pearce is a director and officer of a number of public companies in the resource sector. His professional experience as a practicing attorney is primarily in corporate and securities work. Pearce’s academic background includes an honors bachelor’s degree in economics from York University, in which he focused specifically on corporate finance. Pearce obtained a law degree from the University of British Columbia.

Alfred Kee, COO, is a business technology leader with over 15 years of experience in building high performing teams at small startups to large enterprises. With foundations in running large scale business critical technology and user experience product management mindset, Kee excels at guiding teams to deliver business value with agility. His knowledge and experience were honed while working with Electronic Arts, KPMG, CenturyLink, Cisco and Apple, as well as a string of successful startups. Lee brings a global perspective having lived and worked through parts of the U.S., Canada, Europe and Asia.

Creative Director Amy Yamamura is a founding member of Wildflower and has been a driving force behind the Company from the start, creating the Wildflower brand. After receiving a bachelor’s degree in communications from Boston University, Yamamura returned to Tokyo to develop her career in TV as an international business correspondent coordinating collaborative projects between top creators around the world and corporations. Yamamura’s unique experience in working closely with successful Japanese brands like UNIQLO has given her exceptional eyes for branding a company.

Wildflower Brands Inc. (WLDFF), closed the day's trading session at $0.59, off by 9.23%, on 30,321 volume with 19 trades. The average volume for the last 3 months is 20,237 and the stock's 52-week low/high is $0.009/$1.139.

Recent News

chart

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

Ontario-based VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading provider of first-class cannabis products and services to the medical and adult-use markets, announced on Wednesday that it intends to post the company's financial and operating results for the fiscal fourth quarter and full year 2018 before the markets open on April 30, 2019. To view the full press release, visit: http://nnw.fm/n0kHk.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed the day's trading session at $0.642, off by 2.15%, on 534,068 volume with 170 trades. The average volume for the last 3 months is 319,241 and the stock's 52-week low/high is $0.413/$1.53.

Recent News

chart

City View Green Holdings Inc. (CSE: CVGR)

The QualityStocks Daily Newsletter would like to spotlight City View Green Holdings Inc. (CVGR).

Vertically integrated cannabis company City View Green Holdings (CSE: CVGR) is following its plan to enter the cannabis-edible and beverage markets. The company just entered into a partnership with a leading Jamaican Blue Mountain coffee company. To view the full article, visit: http://nnw.fm/USq0n.

City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.

CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.

Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.

Management

Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.

Market Opportunity

The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.

City View Green Holdings Inc. (CSE: CVGR), closed the day's trading session at $0.14, up 7.69%, on 88,444 volume with 13 trades. The average volume for the last 3 months is 498,674 and the stock's 52-week low/high is $0.10/$0.465.

Recent News

chart

Global Consortium, Inc. (OTC: GCGX)

The QualityStocks Daily Newsletter would like to spotlight Global Consortium, Inc. (OTC: GCGX).

From its headquarters in Florida, Global Consortium Inc. (OTC: GCGX), a diversified cannabis holding company expanding its reach nationwide with several subsidiaries, is evaluating an opportunity to take one of its divisions public in Canada. Cannabis businesses listed in Canada have historically thrived after going public on the Canadian Stock Exchange ("CSE"), which also allows firms to dual list in the United States, as the company noted in a news release (http://nnw.fm/dLzQ4).

Global Consortium, Inc. (OTC: GCGX) is a diversified cannabis holding company that recently acquired several companies in the cannabis space. Headquartered in Florida, Global Consortium is expanding its reach nationwide with several subsidiaries, partnerships and licensing agreements. Golden Consortium reported over $600,000 in sales in the quarter ended September 30, 2018, and over $2 million in CBD product sales for 2018.

Among Global Consortium’s assets are the following:

  • Infused Edibles has been selling a wide selection of specialty, CBD-infused edible products including gummies, baked goods, fruit and nut mixtures, savory and spicy dried fruits and jerky, and cannabidiol oils for over 13 years. Infused Edibles has received 17 first place awards for its dedicated line of U.S. grown, CBD isolate-infused food products. Infused Edibles operates out of a 6,000 square foot building, servicing 400 stores with dedicated sales reps and eight distributors in 15 states.
  • Infused Oils is a northern California company that produces a premium, 100 percent solvent and pesticide-free cannabis distillate that delivers potency, purity and flavor to medical cannabis patients. Infused Oils uses state-of-the-art CO2 supercritical extraction methods to preserve the delicate cannabinoid and full spectrum terpene profiles of its medical grade oil. Produced from uncommon, boutique cannabis strains that are micro-grown and hand trimmed, Infused Oils creates natural, medicinal cannabis extracts that are strain specific THC and CBD oils of premium quality.
  • America’s first Cannabis Mall, under construction in the Sacramento, California, area, is designed to house cannabis manufacturing, distribution, delivery, retail, testing and cultivation – all under one 64,000 square foot building that showcases various cannabis operations from seed to shelf. The Cannabis Mall will house the largest manufacturing facility of THC and CBD distillates and edibles believed to be operational in the United States. The testing lab at the Cannabis Mall will service outside cannabis vendors as well as all products manufactured there. The distribution space will be leased to a 3rd party with a 50 percent revenue share for Global, while all of Global’s products will be distributed free.

Global Consortium recently entered into a Letter of Intent with MJ Munchies, Inc., a subsidiary of Nightfood Holdings, Inc. (OTC: NGTF), for an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked(TM) mark owned by MJ Munchies. The LOI includes provisions for monthly royalty payments, sales and growth thresholds, and a distribution of proceeds if, and when, the Half-Baked brand is ever sold to a third party.

Global Consortium has also received a weekly order, worth a minimum of $50,000 per week, from the only licensed delivery company servicing the Lake Tahoe, Nevada, area. Over 30 million people live in and visit the Lake Tahoe area, which has no recreational dispensaries. As part of the deal, all of Global’s product lines – Infused Edibles, Indulge Oils and any other products produced – will be offered by the delivery company.

Management

Director, CEO and President Matthew Dwyer has been working in the securities industry since 1986 when he began his career working for Donaldson, Lufkin, and Jenrette. Dwyer went on to hold several securities licenses until 1991 when he ventured off on his own. He has worked in all sectors of the industry from owning an Investors Relations company with one of the first call rooms to working on reverse mergers and debt financing. Dwyer has a well-versed working knowledge of the securities industry, working with both OTC and SEC reporting companies.

Director and incoming President Manuel Losada has over 30 years of healthcare industry experience dedicated to building and achieving profitability and growth. His extensive background includes medical/surgical and device manufacturers, distribution and supply chain, group purchasing organizations, pharmaceuticals and medical product delivery systems. Losada holds a proven track record of successful mergers and acquisitions, business development, and long-range planning for Fortune 500 and multinational companies. He is an energetic professional with exceptional analytical, organizational and people skills, strong personal ethics and integrity. Dwyer is a highly organized team-builder with strong leadership experience and excellent communication skills.

Andrew Moll, Independent Director, has worked as a sales rep for approximately 25 years calling on all types of stores including specialty, resorts, sporting goods, casinos, major department stores and mass merchants. Moll worked in private label production overseas and domestic for NASCAR, Wal-Mart, Coca Cola, Six Flags, Disney, Universal Studios, Sea World, and Hard Rock. In addition, he spent 10 years working with U.S. retailers and apparel brands to secure overseas production with factories in Central and South America as well as China, India, and Pakistan. Moll spent the last 8 years as vice president of sales for a resort athleisure company.

Tom Roland, Chief Operating Officer, is the founder of Indulge Oils. Roland has built a strong reputation in the business over the past 5 years for producing a superior product and delivering on time. He will operate the Cannabis Mall and all manufacturing for both the edibles and distillates departments. Roland is a proven entrepreneur experienced in building profitable companies and has a passion for entrepreneurship, developing innovative approaches to industry challenges, and building vibrant company cultures. He accelerates development and deployment of solutions while maintaining profitable growth. Roland also serves as an advisor to several start-up ventures and continues to empower teams though his provocative leadership.

Marc Adesso, Securities Counsel, of Waller Lansden Dortch & Davis, LLP, is recognized for his work on securities regulation and corporate governance. He has established a national practice counseling issuers, conducting mini-IPOs under Regulation A+ of the JOBS Act, which currently allows companies to raise up to $50 million per year from the general public. Adesso is a key member of the firm’s blockchain and cryptocurrency practice and is lauded as one of the world’s top attorneys in the area of registered offerings of cryptocurrencies such as ICOs. In recognition of his national reputation in the space, as well as being Tennessee’s only veteran cannabis attorney, Adesso chairs the firm’s legalized cannabis practice which counsels clients on the rapidly changing landscape facing the cannabis industry.

Global Consortium, Inc. (OTC: GCGX), closed the day's trading session at $0.0275, up 2.23%, on 670,116 volume with 36 trades. The average volume for the last 3 months is 3,123,096 and the stock's 52-week low/high is $0.016/$0.1083.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.